Details

Last Funding Type

Series A

Last Funding Money Raised

Fr20M

Industries

Health Care,Medical,Therapeutics

Founded date

Apr 1, 2019

Number Of Employee

1 - 10

Operating Status

Active

Legal Name

Synendos Therapeutics AG Synendos Therapeutics, Inc.

Synendos Therapeutics develops a class of small molecules for the treatment of anxiety and stress-related disorders. The company also develops breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of the natural functioning of the brain.

The inhibitors act with a new mechanism of action that enables restoration of the natural function of the brain by rebalancing altered neurotransmission in different areas of the bran. There is a high demand for new pharmacological treatments in this area especially for certain diseases such as post-traumatic stress disorder (PTSD) which has a high unmet medical need.